- Home
- NYXH vs SMTI Comparison
NYXH vs SMTI Comparison
Compare NYXH & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- SMTI
- Stock Information
- Founded
- NYXH 2009
- SMTI 1982
- Country
- NYXH Belgium
- SMTI United States
- Employees
- NYXH N/A
- SMTI N/A
- Industry
- NYXH Medical/Dental Instruments
- SMTI Medical/Dental Instruments
- Sector
- NYXH Health Care
- SMTI Health Care
- Exchange
- NYXH Nasdaq
- SMTI Nasdaq
- Market Cap
- NYXH 222.3M
- SMTI 266.7M
- IPO Year
- NYXH 2021
- SMTI N/A
- Fundamental
- Price
- NYXH $5.78
- SMTI $35.10
- Analyst Decision
- NYXH Strong Buy
- SMTI Strong Buy
- Analyst Count
- NYXH 4
- SMTI 2
- Target Price
- NYXH $14.50
- SMTI $48.50
- AVG Volume (30 Days)
- NYXH 117.0K
- SMTI 21.7K
- Earning Date
- NYXH 05-14-2025
- SMTI 05-14-2025
- Dividend Yield
- NYXH N/A
- SMTI N/A
- EPS Growth
- NYXH N/A
- SMTI N/A
- EPS
- NYXH N/A
- SMTI N/A
- Revenue
- NYXH $4,680,609.00
- SMTI $86,672,425.00
- Revenue This Year
- NYXH $323.07
- SMTI $23.68
- Revenue Next Year
- NYXH $204.30
- SMTI $5.80
- P/E Ratio
- NYXH N/A
- SMTI N/A
- Revenue Growth
- NYXH 3.98
- SMTI 33.36
- 52 Week Low
- NYXH $5.55
- SMTI $25.86
- 52 Week High
- NYXH $12.21
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- NYXH 34.87
- SMTI 67.89
- Support Level
- NYXH $6.03
- SMTI $30.54
- Resistance Level
- NYXH $6.66
- SMTI $32.78
- Average True Range (ATR)
- NYXH 0.33
- SMTI 1.09
- MACD
- NYXH 0.11
- SMTI 0.39
- Stochastic Oscillator
- NYXH 15.38
- SMTI 91.18
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.